These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29419480)

  • 1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
    Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
    J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
    J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of
    Weng CC; Hsiao IT; Yang QF; Yao CH; Tai CY; Wu MF; Yen TC; Jang MK; Lin KJ
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.
    Kimura T; Ono M; Seki C; Sampei K; Shimojo M; Kawamura K; Zhang MR; Sahara N; Takado Y; Higuchi M
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4298-4311. PubMed ID: 35798978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
    Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
    J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.
    Kimura Y; Ichise M; Ito H; Shimada H; Ikoma Y; Seki C; Takano H; Kitamura S; Shinotoh H; Kawamura K; Zhang MR; Sahara N; Suhara T; Higuchi M
    J Nucl Med; 2015 Sep; 56(9):1359-65. PubMed ID: 26182966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
    Maruyama M; Shimada H; Suhara T; Shinotoh H; Ji B; Maeda J; Zhang MR; Trojanowski JQ; Lee VM; Ono M; Masamoto K; Takano H; Sahara N; Iwata N; Okamura N; Furumoto S; Kudo Y; Chang Q; Saido TC; Takashima A; Lewis J; Jang MK; Aoki I; Ito H; Higuchi M
    Neuron; 2013 Sep; 79(6):1094-108. PubMed ID: 24050400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo reactive astrocyte imaging using [
    Kong Y; Cao L; Wang J; Zhuang J; Xie F; Zuo C; Huang Q; Shi K; Rominger A; Li M; Wu P; Guan Y; Ni R
    J Neurol Sci; 2024 Jul; 462():123079. PubMed ID: 38878650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.
    Takahata K; Kimura Y; Sahara N; Koga S; Shimada H; Ichise M; Saito F; Moriguchi S; Kitamura S; Kubota M; Umeda S; Niwa F; Mizushima J; Morimoto Y; Funayama M; Tabuchi H; Bieniek KF; Kawamura K; Zhang MR; Dickson DW; Mimura M; Kato M; Suhara T; Higuchi M
    Brain; 2019 Oct; 142(10):3265-3279. PubMed ID: 31504227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
    Tagai K; Ono M; Kubota M; Kitamura S; Takahata K; Seki C; Takado Y; Shinotoh H; Sano Y; Yamamoto Y; Matsuoka K; Takuwa H; Shimojo M; Takahashi M; Kawamura K; Kikuchi T; Okada M; Akiyama H; Suzuki H; Onaya M; Takeda T; Arai K; Arai N; Araki N; Saito Y; Trojanowski JQ; Lee VMY; Mishra SK; Yamaguchi Y; Kimura Y; Ichise M; Tomita Y; Zhang MR; Suhara T; Shigeta M; Sahara N; Higuchi M; Shimada H
    Neuron; 2021 Jan; 109(1):42-58.e8. PubMed ID: 33125873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
    Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
    Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
    Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
    J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-8719, a Novel and Selective
    Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
    J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynthesis and quality control testing of the tau imaging positron emission tomography tracer [
    Kawamura K; Hashimoto H; Furutsuka K; Ohkubo T; Fujishiro T; Togashi T; Arashi D; Sakai T; Muto M; Ogawa M; Kurihara Y; Nengaki N; Takei M; Nemoto K; Higuchi M; Zhang MR
    J Labelled Comp Radiopharm; 2021 Mar; 64(3):109-119. PubMed ID: 33067819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Cselényi Z; Wallin J; Tjerkoski J; Bloth B; Svensson S; Nennesmo I; Sunnemark D; Jelic V; Farde L; Svenningsson P
    Synapse; 2023 Jul; 77(4):e22269. PubMed ID: 36951466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy.
    Barron AM; Ji B; Fujinaga M; Zhang MR; Suhara T; Sahara N; Aoki I; Tsukada H; Higuchi M
    Neurobiol Aging; 2020 Oct; 94():140-148. PubMed ID: 32623260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.